Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000713578 | SCV000338288 | uncertain significance | not provided | 2016-01-08 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000713578 | SCV000844203 | uncertain significance | not provided | 2022-07-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000809728 | SCV000949899 | uncertain significance | Autosomal recessive ataxia, Beauce type; Emery-Dreifuss muscular dystrophy 4, autosomal dominant | 2022-10-21 | criteria provided, single submitter | clinical testing | This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 3602 of the SYNE1 protein (p.Asn3602Ser). This variant is present in population databases (rs148212715, gnomAD 0.03%). This missense change has been observed in individual(s) with cerebellar ataxia, congenital cerebellar hypoplasia, and cognitive impairment (PMID: 30275942). ClinVar contains an entry for this variant (Variation ID: 285321). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The serine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Revvity Omics, |
RCV000713578 | SCV003824682 | uncertain significance | not provided | 2019-08-27 | criteria provided, single submitter | clinical testing |